FDAnews
www.fdanews.com/articles/114299-intermune-posts-mixed-results-on-lung-drug

InterMune Posts Mixed Results on Lung Drug

February 3, 2009
InterMune reported mixed results from two pivotal clinical trials of the company’s experimental drug pirfenidone in patients with idiopathic pulmonary fibrosis, a progressive and fatal lung disease.
TheStreet.com